- Report
- October 2024
- 187 Pages
Global
From €3371EUR$3,545USD£2,834GBP
€3745EUR$3,939USD£3,149GBP
- Report
- March 2025
- 93 Pages
Global
From €5324EUR$5,600USD£4,477GBP
- Report
- July 2024
- 180 Pages
Global
From €4279EUR$4,500USD£3,598GBP
- Report
- September 2024
Global
From €4563EUR$4,799USD£3,837GBP
- Report
- September 2024
- 337 Pages
Global
From €4706EUR$4,950USD£3,958GBP
- Report
- May 2024
- 170 Pages
Global
From €5657EUR$5,950USD£4,757GBP
- Report
- March 2025
- 139 Pages
Global
From €2851EUR$2,999USD£2,398GBP
- Report
- March 2025
- 120 Pages
Global
From €5324EUR$5,600USD£4,477GBP
- Report
- March 2025
- 194 Pages
Global
From €4706EUR$4,950USD£3,958GBP
- Report
- March 2025
- 277 Pages
Global
From €5515EUR$5,800USD£4,637GBP
- Report
- July 2024
- 200 Pages
Global
From €2177EUR$2,290USD£1,831GBP
- Report
- February 2025
- 200 Pages
Global
From €4269EUR$4,490USD£3,590GBP
- Report
- February 2025
- 200 Pages
Global
From €4269EUR$4,490USD£3,590GBP
- Report
- February 2025
- 183 Pages
Global
From €4279EUR$4,500USD£3,598GBP
- Report
- January 2025
- 182 Pages
Global
From €4279EUR$4,500USD£3,598GBP
- Report
- August 2024
- 182 Pages
Global
From €4279EUR$4,500USD£3,598GBP
- Report
- December 2024
Global
From €7131EUR$7,500USD£5,996GBP
- Report
- February 2025
- 215 Pages
Global
From €3851EUR$4,050USD£3,238GBP
- Report
- April 2024
- 130 Pages
North America
From €3803EUR$4,000USD£3,198GBP
- Report
- October 2022
- 115 Pages
Global
From €3090EUR$3,250USD£2,598GBP

The Extracellular Matrix Patch (ECMP) market is a subset of the biomaterials industry. ECMPs are biocompatible materials that are used to repair or replace damaged tissue. They are composed of natural or synthetic extracellular matrix components, such as collagen, elastin, and glycosaminoglycans. ECMPs are used in a variety of medical applications, including wound healing, tissue engineering, and regenerative medicine.
ECMPs have been used in clinical trials for a variety of conditions, including chronic wounds, diabetic foot ulcers, and burns. They have been shown to be effective in promoting wound healing and tissue regeneration. ECMPs are also being studied for their potential use in treating other conditions, such as cardiovascular disease and cancer.
The ECMP market is expected to grow in the coming years, driven by increasing demand for tissue regeneration and wound healing products. The market is also expected to benefit from advances in technology, such as 3D printing and stem cell therapy.
Some of the major players in the ECMP market include Organogenesis, MiMedx, Integra LifeSciences, and Acelity. Show Less Read more